Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management

• Autore: Komosinska-Vassev Katarzyna
• Pubblicazione: Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
• Descrizione fisica: 1 online resource (208 p.)
• Soggetto topico: Medicine and Nursing
• Soggetto non controllato: adipokines; adiponectin; antiplatelet therapy; bone turnover markers; breast cancer; cardiovascular disease; case control study; CCL11; CCL24; CCL26; CCR3; CRC; Crohn's disease; Crohn's disease (CD); CTX-I; dendritic cells; diabetes; extracellular matrix; extracellular matrix components; FSHR; hedgehog-interacting protein; hyaluronan; hyaluronan (HA); impaired fasting glucose; impaired glucose tolerance; inflammatory bowel disease; inflammatory bowel diseases (IBD); innate lymphoid cells; interleukin 21; interleukin 22; Let-7e; lymphocytes; macrophages; microRNA; miR-125a-3p; miR-126; miR-223; mortality; newly diagnosed diabetes; NGS variants; normal glucose tolerance; NTX-I; obesity; ovarian cancer; overweight; personalized drug therapy; personalized medicine; pharmacogenomics; PICP; PINP; platelet reactivity; proteins; RANKL/OPG; rheumatoid arthritis; rheumatology; soluble part of syndecan-1 (sCD138); sulfated glycosaminoglycans (sGAG); TNF-α inhibitors; tumor microenvironment; tumorigenesis; ulcerative colitis; ulcerative colitis (UC)
• Persona (resp. second.): OlczykPawel; Komosinska-VassevKatarzyna
• Sommario/riassunto: This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
• Titolo autorizzato: Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910566458203321
• Lo trovi qui: Univ. Federico II